Today is International Day of People with Disabilities

December 03, 2014 – Established in 1992, International Day of People with Disabilities is a United Nations sanctioned day that aims to promote an understanding of people with disabilities and encourage support for their dignity, rights and well-being.

People with disabilities often face barriers, including physical, social, economic, educational, attitudinal and health care barriers. There are many types of disabilities and impairments, both visible and invisible.

More than 1 billion people live with a disability, says the world report on disability, published …

/by

Sandoz supports HIV/AIDS awareness and increased access to treatment for this major global public health issue

December 01, 2014 – According to the World Health Organization (WHO), Human Immunodeficiency Virus (HIV/AIDS) has caused the deaths of millions of people and is one of the most destructive pandemics in history. World AIDS Day, celebrated annually on December 1st, was established by the WHO in 1988 to raise awareness of the virus, which is preventable and treatable.

HIV attacks the body’s immune system, the body’s defense against diseases. HIV can be passed on through infected bodily fluids, most commonly …

/by

Sandoz supports HIV/AIDS awareness and increased access to treatment for this major global public health issue

December 01, 2014 – According to the World Health Organization (WHO), Human Immunodeficiency Virus (HIV/AIDS) has caused the deaths of millions of people and is one of the most destructive pandemics in history. World AIDS Day, celebrated annually on December 1st, was established by the WHO in 1988 to raise awareness of the virus, which is preventable and treatable.

HIV attacks the body’s immune system, the body’s defense against diseases. HIV can be passed on through infected bodily fluids, most commonly …

/by

Sandoz launches biosimilar Filgrastim BS Injection 75 µg/150 µg/ 300 µg Syringe in Japan

Tokyo, Japan, December 1, 2014 ― Sandoz, the generic pharmaceutical division of Novartis, today announced the launch in Japan of biosimilar Filgrastim BS Injection 75µg / 150µg / 300µg Syringe. Filgrastim is used with certain cancer patients to accelerate recovery of infection-fighting white blood cells after chemotherapy (prevention of neutropenia) and is also used to stimulate mobilization of hematopoietic stem cells for collection and transplantation.

“As the pioneer and global leader in biosimilars we are very pleased to announce the launch of our second …

/by

Sandoz launches biosimilar Filgrastim BS Injection 75 µg/150 µg/ 300 µg Syringe in Japan

Tokyo, Japan, December 1, 2014 ― Sandoz, the generic pharmaceutical division of Novartis, today announced the launch in Japan of biosimilar Filgrastim BS Injection 75µg / 150µg / 300µg Syringe. Filgrastim is used with certain cancer patients to accelerate recovery of infection-fighting white blood cells after chemotherapy (prevention of neutropenia) and is also used to stimulate mobilization of hematopoietic stem cells for collection and transplantation.

“As the pioneer and global leader in biosimilars we are very pleased to announce the launch of our second …

/by

Sandoz receives approvals in Ireland and Czech Republic for innovative respiratory inhaler AirFluSal® Forspiro®

  • Regulatory authorities in Ireland and Czech Republic grant marketing authorizations for AirFluSal® Forspiro®
  • Approval for 50-250 and 50-500µg dosage forms
  • AirFluSal Forspiro already launched in four European countries and South Korea

Holzkirchen, November 19, 2014 – Sandoz announces today that the pharmaceutical regulatory authorities in Ireland and the Czech Republic have granted marketing authorizations for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and/or chronic obstructive pulmonary disease (COPD).

…

/by

Sandoz commits to increasing patient access to important respiratory treatments

November 19, 2014 – Today, on World Chronic Obstructive Pulmonary Disease (COPD) Day, Sandoz reaffirms its commitment to providing needed treatments for respiratory conditions such as COPD. COPD is a progressive disease that makes it hard to breathe, with symptoms that can affect aspects of everyday life1,2.

The most common symptoms of COPD include shortness of breath, abnormal sputum production, a chronic cough, wheezing and chest tightness4. Daily activities, such as walking up a short flight of stairs, can become very difficult as the condition …

/by

Global health challenges – including life expectancy – are influenced by gender

November 19, 2014 – The health challenges facing both men and women globally are heavily influenced by gender. Today, International Men’s Day, the global health community seeks to promote positive male role models, celebrate men’s positive contributions to society, focus on men’s health and wellbeing, highlight discrimination against males, and improve gender relations and promote gender equality.

Globally, men die younger than women. There are a number of reasons for this, such as biological, societal and behavioral differences.

Gender differences in health …

/by

Sandoz supports prudent use of antibiotics on EU Antibiotic Awareness Day

November 18, 2014 – European Antibiotic Awareness Day is an annual European public health initiative to raise awareness about the threat to public health of antibiotic resistance and the importance of prudent antibiotic use.

The latest data confirms that across the European Union the number of patients infected by resistant bacteria is increasing and that antibiotic resistance is a major threat to public health.

Prudent use of antibiotics can help stop resistant bacteria from developing and help keep antibiotics effective for the use of future generations.

…

/by

Sandoz sponsors diabetes awareness training for healthcare professionals in Ethiopia

November 14, 2014 – Today is World Diabetes Day. Globally, 382 million people were living with diabetes in 2013. In 2035, it is estimated that 592 million people will be living with diabetes, a 55% increase from today1.

In sub-Saharan Africa, non-communicable diseases like diabetes are on the rise2. However, many African countries are ill-prepared to deal with these new healthcare challenges2.

In Ethiopia, Sandoz has initiated a new project called Sandoz Executive Medical Management Academy (SEMMA), an educational program for …

/by